Inventor
CAUFIELD CRAIG E
US35 patents
⚠️ This page may combine multiple inventors who share the name “CAUFIELD CRAIG E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMERICAN HOME PROD
25 patentsUS5378836AJan 3, 1995
Rapamycin oximes and hydrazones
AMERICAN HOME PROD180 citations99
US5221670AJun 22, 1993
Rapamycin esters
AMERICAN HOME PROD233 citations99
US5151413ASep 29, 1992
Rapamycin acetals as immunosuppressant and antifungal agents
AMERICAN HOME PROD462 citations99
US5130307AJul 14, 1992
Aminoesters of rapamycin
AMERICAN HOME PROD220 citations99
US5118677AJun 2, 1992
Amide esters of rapamycin
AMERICAN HOME PROD443 citations99
US5102876AApr 7, 1992
Reduction products of rapamycin
AMERICAN HOME PROD180 citations99
US5023264AJun 11, 1991
Rapamycin oximes
AMERICAN HOME PROD204 citations99
US5378696AJan 3, 1995
Rapamycin esters
AMERICAN HOME PROD120 citations98
US5373014ADec 13, 1994
Rapamycin oximes
AMERICAN HOME PROD153 citations98
US5286730AFeb 15, 1994
Method of treating immunoinflammatory disease
AMERICAN HOME PROD118 citations98
US5023262AJun 11, 1991
Hydrogenated rapamycin derivatives
AMERICAN HOME PROD268 citations98
US5525610AJun 11, 1996
42-Epi-rapamycin and pharmaceutical compositions thereof
AMERICAN HOME PROD132 citations97
US5830911ANov 3, 1998
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
AMERICAN HOME PROD85 citations96
US5286731AFeb 15, 1994
Method of treating immunoinflammatory bowel disease
AMERICAN HOME PROD106 citations96
US6328970B1Dec 11, 2001
Rapamycin position 27 conjugates
AMERICAN HOME PROD81 citations95
US5776967AJul 7, 1998
Pyranoindole inhibitors of COX--2
AMERICAN HOME PROD82 citations95
US5446048AAug 29, 1995
Rapamycin oximes
AMERICAN HOME PROD84 citations95
US5358944AOct 25, 1994
Rapamycin esters for treating transplantation rejection
AMERICAN HOME PROD35 citations93
US5824699AOct 20, 1998
Carbazole inhibitors of Cox-2
AMERICAN HOME PROD43 citations92
US5066671ANov 19, 1991
Ellagic acid derivatives as phospholipase A2 inhibitors
AMERICAN HOME PROD19 citations82
US5679801AOct 21, 1997
Tetronic and thiotetronic acid derivatives as phospholipase A2 inhibitors
AMERICAN HOME PROD7 citations73
US5242945ASep 7, 1993
Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors
AMERICAN HOME PROD15 citations73
US5366993ANov 22, 1994
Tetronic, thiotetronic and tetramic acid derivatives as phospholipase A.sub.
AMERICAN HOME PROD6 citations70
US5420153AMay 30, 1995
Tetronic, thiotetronic and tetramic acid derivatives as phospholipase A.sub.
AMERICAN HOME PROD3 citations59
US5468774ANov 21, 1995
Tetronic, thiotetronic and tetramic acid derivatives as phospholipase A.sub.
AMERICAN HOME PROD0 citations48
WYETH CORP
8 patentsUS6541612B2Apr 1, 2003
Monoclonal antibodies obtained using rapamycin position 27 conjugates as an immunogen
WYETH CORP63 citations95
US7279562B2Oct 9, 2007
Rapamycin conjugates
WYETH CORP29 citations92
US6930131B2Aug 16, 2005
Aryl substituted 3-ethoxy phenyl trifluoromethane sulfonamides for the treatment of non-insulin dependent diabetes mellitus (NIDDM)
WYETH CORP32 citations87
US7279561B1Oct 9, 2007
Anti-rapamycin monoclonal antibodies
WYETH CORP6 citations73
US6765021B2Jul 20, 2004
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
WYETH CORP11 citations72
US7008636B2Mar 7, 2006
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
WYETH CORP0 citations50
US6451827B2Sep 17, 2002
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
WYETH CORP1 citations50
US6933322B2Aug 23, 2005
Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
WYETH CORP0 citations35